FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Guide on Interstitial Cystitis/Bladder Pain Syndrome

Federal Register notice: FDA makes available a draft guidance entitled Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): Establishing Effectivenes...

Medical Devices

EmCyte Progenikine Concentrating System Cleared

FDA clears an EmCyte 510(k) for its Progenikine Concentrating System for adipose lipoplasty.

Human Drugs

Interstitial Cystitis Drug Effectiveness Guidance

FDA publishes a draft guidance with recommendations for establishing effectiveness for drugs intended to treat patients with interstitial cystitis/bla...

Federal Register

Pilot Considered on Evaluating Novel Excipients

Federal Register notice: FDA establishes a docket to obtain information and comments that will assist it in determining whether to establish a pilot p...

Medical Devices

CDRH Industry Basics Webcast

A CDRH Industry Basics webcast gives basic program information on the 513(g) device determination and classification process and the custom device exe...

Federal Register

Reg Review Period for Sparks Luxturna

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Spark Therapeutics Luxturna.

Medical Devices

Jobs Lost if Medical Device Tax Not Repealed: Analysis

AdvaMed says that if Congress does not repeal the medical device tax before the end of the year, more than 20,000 industry jobs will be lost in the ne...

FDA General

FDA Should Consider Free Speech Decisions: MIWG

The Medical Information Working Group says FDA should incorporate principles from five recent Supreme Court free speech decisions into its considerati...

Federal Register

Oncology Panel Review AstraZeneca, Merck

Federal Register notice: FDA announces a 12/17 Oncologic Drugs Advisory Committee meeting that with discuss an AstraZeneca supplemental NDA for Lynpar...

Human Drugs

Rising Pharma Paying Over $3 Million in Price Fixing Charge

The Justice Department says Rising Pharmaceuticals will pay over $3 million to resolve price fixing charges and will cooperate with an ongoing investi...